Insider Transactions in Q1 2025 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2025
|
Kristin Abate Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
571
-5.55%
|
$3,426
$6.29 P/Share
|
|
Mar 04
2025
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,548
-11.46%
|
$21,288
$6.29 P/Share
|
|
Mar 04
2025
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,587
-10.92%
|
$21,522
$6.29 P/Share
|
|
Mar 04
2025
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
11,694
-12.35%
|
$70,164
$6.29 P/Share
|
|
Mar 04
2025
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,445
-9.12%
|
$20,670
$6.29 P/Share
|
|
Mar 04
2025
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
2,793
-11.72%
|
$16,758
$6.29 P/Share
|
|
Feb 28
2025
|
Richard A. Paulson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+17.44%
|
-
|
|
Feb 28
2025
|
Kristin Abate Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
933
+8.32%
|
-
|
|
Feb 28
2025
|
Stuart Poulton EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,583
+14.41%
|
-
|
|
Feb 28
2025
|
Reshma Rangwala EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,999
+14.16%
|
-
|
|
Feb 28
2025
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,999
+12.43%
|
-
|
|
Feb 28
2025
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,583
+11.0%
|
-
|
|
Feb 18
2025
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,914
-1.81%
|
$0
$0.63 P/Share
|
|
Feb 04
2025
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
4,099
-0.36%
|
$0
$0.65 P/Share
|
|
Jan 31
2025
|
Lori Macomber EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+50.0%
|
-
|
|
Jan 06
2025
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
4,055
-0.36%
|
$0
$0.78 P/Share
|